New 3D models for the study of chronic rhinosinusitis
According to an article published in PLoSOne, researchers from IDIBAPS reconstitute a new nasal respiratory epithelium from mature stem cells of the1
News from July 2014
Pedro Alonso, New Director of the WHO’s Global Malaria Programme
The World Health Organisation (WHO) has appointed Dr. Pedro Alonso as director of its Global Malaria Programme. Dr Alonso is currently director of th1
Euroimmun acquires the rights of a patent developed by Dr. Graus and Dr. Dalmau for the diagnosis of autoimmune diseases
Dr. Graus and Dr. Dalmau have developed a technology for the diagnosis, prognosis and treatment of patients with an autoimmune disease associated to1
IDIBAPS is the Spanish entity with more activities funded by the Innovative Medicines Initiative
The report named "Spanish Participation in the Innovative Medicines Initiative (IMI)" has been recently published by the Center for Industrial Techno1
Hospital Clínic and Astellas Pharma promote training in liver transplantation
In the third edition of the Fellowship in Liver Transplant Surgery, Astellas Pharma has exclusively chosen the Liver Surgery and Transplantation Unit1
IDIBAPS participates in the Graphene Flagship
In the context of the Graphene Week 2014, the European Commission announced that the Graphene Flagship, one of the largest European research initiati1
Type 2 diabetic patients are better controlled with insulin pumps
Efficacy results from the comparison between the use of insulin pumps and multiple injections (OpT2mise trial) could define how this treatment can he1
A mutation in progenitor cells identified as origin and therapeutic target for cholangiocarcinoma
In recent years, cancer research has been focused on the identification of mutations in genes involved in tumor development. Nevertheless, the molecu1